I'm LongbridgeAI. Here is the key information I extracted- The single covering institution maintains a strong buy consensus rating with a target price of 43.86 USD, which is 1849 % above the current price.…
The Week
Zepp Health added 2.27% this week to close at $2.25, while the S&P 500 fell 2.68% — leaving the stock roughly 4.95 percentage points ahead of the benchmark. The weekly range ran from $2.20 to $2.45 as Monday opened at $2.20 and briefly touched $2.45 before pulling back; Wednesday closed at $2.28 and Friday ended at $2.25. The week had no major catalysts, with news limited to two intraday swings.
Analyst Ratings
Coverage on Zepp Health totals one broker, which rates it a buy. The consensus rating is strong buy, with a consensus target of $43.86 — about 1,849% above the last close of $2.25. The target range shows no dispersion, with both the high and low at $43.86. Within the electronic equipment and services industry, the stock ranks 53rd out of 67 names.
The Week Ahead
Tuesday brings US CPI and core CPI prints. Headline CPI has a prior reading of 3.7% with a 3.9% estimate, while core CPI comes in at 2.6% prior and 2.8% expected, alongside the NFIB Small Business Optimism Index. On the company front, Zepp Health reports fiscal Q3 2026 earnings before the open on 2 December, so attention will start shifting towards that window after next week.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
